Ceftibuten Dihydrate

头孢布烯

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCeftibuten Dihydrate
Drug Alias NameCeftibutenum头孢布西二水合物头孢布腾二水合物头孢布稀二水合物头孢布烯二水合物 +[16] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsOtitis MediaTonsillitisPharyngitis +[8] 
Global Approved IndicationsOtitis MediaTonsillitisPharyngitis +[8] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1992/01/01
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPernix
China Registration ClassN/A

Develop Information

Active CompaniesPernix
Inactive CompaniesBurke Therapeutics Llc
Active IndicationsCommunicable DiseasesGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Inactive IndicationsOtitis MediaTonsillitisPharyngitis +[5] 

Other Information

ATC CodeJ01DD14
Related LinksWikipediaDrugBankKEGG